Hydrotherapy for spasticity in Strumpell-Lorrain disease
case report
DOI:
https://doi.org/10.34024/rnc.2009.v17.8608Keywords:
Spastic Paraparesis, Hydrotherapy, RehabilitationAbstract
The hereditary spastic paraparesis (HSP) or Strumpell-Lorrain disease is a progressive disorder formed by a group of neurodegenerative conditions whose main clinical characteristic is the muscular weakness associated the varied degrees of spasticity in the lower limbs, being caused for a disturbance in the development or gradual degeneration of the pyramidal tract. The spasticity has been described as a motor disorder, characterized for the increase of the speed-dependent in the reflexes tonic of stretching and hyperactivity of the deep reflexes. Patients with HSP declare that innumerable functional abilities become injured by the association of the muscular weakness and spasticity. The hydrotherapy and its properties constitute an alternative for the physical rehabilitation of neurological patients. We report the case of a patient with HSP and suggest some proposals of rehabilitation in aquatic environment.
Downloads
References
McDermott CJ, White K, Bushby K, Shaw PJ. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatr 2000;69:150-60.
Harding AE. Hereditary spastic paraplegias. Semin Neurol 1993;13(4):333-6.
Reid E. Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet 2003;40:81-6.
Kesiktas N, Paker N, Erdogan N, Gülsen G, Biçki D, Yilmaz H. The Use of Hydrotherapy for the Management of Spasticity. Neurorehabilitation and Neural Repair 2004;18(4):268-73.
Becker EB. Biophysiologic aspects of hydrotherapy. In: Becker EB, Cole AC (eds.). Comprehensive aquatic therapy. Newton: ButterworthHeinemann, 1997, 17-48.
Koury JM. Benefits of an aquatic therapy program. In: Koury JM (ed.). Aquatic therapy programming. Champaign: Human Kinetics, 1996, 1-11.
Medical Research Council. Aids to the investigation of peripheral nerve injuries. War Memorandum, 2nd edition. London: HMSO, 1943, 1-2.
Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67:206-7.
Harding AE. Hereditary pure spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatr 1981;44:871-83.
Dürr A, Brice A, Serdaru M, Rancurel G, Derouesné C, Lyon-Caen O, et al. The phenotype of pure autosomal dominant spastic paraplegia. Neurology 1994;44:1274-7.
Polo JM, Calleja J, Combarros O, Berciano J. Herditary pure spastic paraplegia: a study of nine families. J Neurol Neurosurg Psychiatr 1993;56:175-81.
Aalfs CM, Koelman JHTM, Meyjes FE, Ongerboer de Visser BW. Posterior tibial and sural nerve somatosensory evoked potentials: a study in spastic paraparesis and spinal cord lesions. Electroencephalogr Clin Neurophysiol 1993;89:437–41.
Pelosi L, Lanzillo B, Perretti A, Santoro L, Blumhardt L, Caruso G. Motor and somatosensory evoked potentials in hereditary spastic paraplegia. J Neurol Neurosurg Psychiatr 1991;54:1099-102.
Lossos A, Stevanin G, Meiner V, Argov Z, Bouslam N, Newman JP, et al. Hereditary Spastic Paraplegia With Thin Corpus Callosum. Arch Neurol 2006;63:756-60.
Teive HA, Iwamoto FM, Camargo CH, Lopes-Cendes I, Werneck LC. Doença de Machado-Joseph versus paraplegia espástica hereditária: relato de caso. Arq Neuropsiquiatr 2001; 59(3B):809-11.
Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 2006;43:259-65.
Hedera P, Fenichel GM, Blair M, Haines JL. Novel Mutation in the SPG3A Gene in an African American Family with an Early Onset of Hereditary Spastic Paraplegia. Arch Neurol 2004;61:1600-3.
Fink JK, Heineman-Patterson T, Bird T, Cambi F, Dubé MP, Figlewicz DA, et al. Hereditary spastic paraplegia: advances in genetic research. Neurology 1996;46:1507-14.
Hentati A, Pericak-Vance MA, HungWY, Belal S, Laing N, Boustany RM, et al. Linkage of pure autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet 1994;3:1263-7.
De Michele G, De Fusco M, Cavalcanti F, Filla A, Marconi R, Volpe G, et al. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet 1998;63:135-9.
Murillo F, Kobayashi H, Pegoraro E, Galluzzi G, Creel G, Mariani C, et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13–15. Neurology 1999;53:50-6.
Kenwrick S, Ionasescu V, Ionasescu G, Searby C, King A, Dubowitz M, et al. Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Hum Genet 1986;73:264-6.
Keppen LD, Leppert MF, O’Connel P, Nakamura Y, Stauffer D, Lathrop M, et al. Etiological heterogeneity in X-linked spastic paraplegia. Am J Hum Genet 1987;41:933-43.
Tallaksen CME, Dürr A, Brice A. Recent advances in hereditary spastic paraplegia. Cur Opin Neurol 2001;14: 457-63.
Walton K. Management of patients with spasticity – A practical approach. Prac Neurol 2003;3:342-53.
Pagliaro P, Zamparo P. Quantitative evaluation of the stretch reflex before and after hydro kinesy therapy in patients affected by spastic paresis. J Electromyogr Kinesiol 1999;9(2):141-8.
Driver S, O’Connor J, Lox C, Rees K. Evaluation of an aquatics programme on fitness parameters of individuals with a brain injury. Brain Inj 2004;18(9):847-59.
Dumas HM, O’Neil ME, Fragala MA. Expert consensus on physical therapist intervention after botulinum toxin A injection for children with cerebral palsy. Pediatr Phys Ther 2001;13:122-32.
Malouin F, Richards CL, McFadyen B, Doyon J. Nouvelles perspectives en réadaptation motrice après un accident vasculaire cerebral. Med Sci (Paris) 2003;19:994-8.
Português
English
Español
